SCHEMBL10148088

SCHEMBL10148088

CC(C)C(=O)n1c2ccccc2c2cc(C(N)=O)c(N)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.41
▸ LMNA P02545 6/20 0.38
▸ MAPT P10636 6/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HTT P42858 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ IKBKB O14920 1/20 0.36
▸ OPRM1 P35372 1/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ OPRL1 P41146 1/20 0.36
▸ PTGS2 P35354 2/20 0.36
▸ PABPC1 P11940 2/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL396899 0.79 RCE1 (0.49) POLBLMNAMAPTALDH1A1HTT
SCHEMBL10148077 0.76 KDM4E (0.58) POLBLMNAMAPTALDH1A1HTT
SCHEMBL13105848 0.75 KDM4E (0.45) POLBLMNAMAPTALDH1A1HTT
SCHEMBL2483599 0.72 KDM4E (0.54) POLBLMNAMAPTALDH1A1HTT
SCHEMBL10148197 0.69 TSPO (0.41) POLBLMNAMAPTALDH1A1HTT
SCHEMBL11921099 0.68 POLB (0.40) POLBLMNAMAPTALDH1A1HTT
SCHEMBL398382 0.66 RCE1 (0.52) POLBLMNAMAPTALDH1A1HTT
SCHEMBL396864 0.65 RCE1 (0.51) POLBMAPTALDH1A1HTTHPGD
SCHEMBL13325029 0.64 POLB (0.53) POLBLMNAMAPTALDH1A1HTT
SCHEMBL2484972 0.64 RAB9A (0.48) POLBLMNAMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101604-B2 Alpha carbolines and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-01-24 — — US disclosed
US-8101604-B2 Alpha carbolines and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-01-24 — — US disclosed
US-20100311715-A1 ALPHA CARBOLINES AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-12-09 — — US disclosed
US-20100311715-A1 ALPHA CARBOLINES AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311715-A1 ALPHA CARBOLINES AND USES THEREOF CHRM1, CNR1, CXCR1 POLB 2829/4885LMNA 3133/4885MAPT 3493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback